Across TCGA pan-cancer cohorts, MIR8088 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of MIR8088’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where MIR8088 RNA is repressed in tumor relative to normal tissue. In most cancer types MIR8088 is over-expressed in tumor, although a few such as LUSC show the opposite, repressed pattern.
LUSC are the cancer types where MIR8088 tumor–normal differential expression is most reproducible.